Algerian Pharmaceutical Industry Minister Ouacim Kouidri oversaw the relaunch of the industrial unit project for producing raw materials and veterinary vaccines on Thursday in Mostaganem province. The plant is operated by the state-owned pharmaceutical group Saidal.
In a press statement following his site visit, Kouidri said that this important project, specializing in veterinary product manufacturing from raw materials through to finished goods, had experienced an “unacceptable” shutdown. This halt has resulted in hard currency waste, as the state has been forced to purchase veterinary vaccines at steep prices to protect the nation’s livestock.
He added that the arrival of these vaccines to Algeria costs additional burdens, particularly given the evolving viral threats to animals and the resulting livestock losses.
He noted that construction work will resume today at an accelerated pace, with a view to launching production as soon as possible.
The project’s administrative complex is 96 percent complete, while the production buildings are nearing completion at 95 percent. According to briefings given to the minister, the facility will have an annual production capacity of 175 tons, particularly for raw materials.
